Optiscan Imaging Stock

Optiscan Imaging EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Optiscan Imaging (OIL.AX) as of Aug 5, 2026 is -13.45. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -13.48 — a change of -0.24% (higher).

EV/EBIT

-13.45

YoY

-0.24%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Optiscan Imaging is 2026 -13.45 . EV/EBIT (Enterprise Value to EBIT) of Optiscan Imaging was 2025 -13.48 . It decreases by -0.24% higher compared to the previous year.

The Optiscan Imaging EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2018
-5.89 base
Jan 1, 2019
-4.41 base
Jan 1, 2020
-29.22 base
Jan 1, 2021
-43.53 base
Jan 1, 2022
-14.61 base
Jan 1, 2023
-12.22 base
Jan 1, 2024
-20.76 base
Jan 1, 2025
-12.74 base
YEARPRICE-TO-EBIT
2025 -12.74
2024 -20.76
2023 -12.22
2022 -14.61
2021 -43.53
2020 -29.22
2019 -4.41
2018 -5.89
2017 -7.30
2016 -6.23
2015 -2.53
2014 -3.98
2013 -8.27
2012 -2.92
2011 -
2010 -2.45
2009 -0.96
2008 -0.76
2007 -5.92
2006 -4.23
Access this data via the Eulerpool API

Optiscan Imaging Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Optiscan Imaging's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Optiscan Imaging's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Optiscan Imaging's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Optiscan Imaging grows earnings faster than its peers.

Optiscan Imaging Stock analysis

What does Optiscan Imaging do? Optiscan Imaging Ltd is an Australian company specializing in the development and commercialization of advanced imaging technologies. The company was founded in 1994 and is headquartered in Notting Hill, a suburb of Melbourne. Optiscan was originally established as a spin-off company from Monash University to enable the commercial application of a groundbreaking technology called confocal microscopy. However, over the years, the company has expanded into other imaging technologies and now offers a wide range of products and services. Optiscan's business model involves developing and bringing to market innovative technologies that can be used in biomedical research and clinical diagnostics. The company works closely with research institutions and companies in various industries to develop customized imaging solutions. Optiscan offers a wide range of products, including confocal microscopes, multiphotonic microscopes, real-time imaging systems, and Raman spectrometers. These products are used in various application areas such as cancer research, neurobiology, cell biology, and materials science. Another important area for Optiscan is veterinary imaging. The company has developed a product line for veterinary medicine that is used by veterinarians and researchers around the world. Optiscan's imaging systems enable veterinarians to obtain precise and detailed images of animals to enable better diagnosis and treatment. Optiscan also operates a service department that offers customized imaging solutions to customers. The company provides services such as image processing, data analysis, and prototype development. Overall, Optiscan has become one of the leading providers of imaging technologies in Australia and globally over the past decades. The company has a long history of collaboration with leading research institutions and companies worldwide and remains committed to developing innovative solutions for the challenges of biomedicine and imaging. Optiscan Imaging is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Optiscan Imaging stock

EV/EBIT (Enterprise Value to EBIT) of Optiscan Imaging is -13.45 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Optiscan Imaging changed from -13.48 to -13.45, representing a -0.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Optiscan Imaging since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Optiscan Imaging with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Optiscan Imaging

All Key Metrics — Optiscan Imaging